Phytotoxins Produced by Fungi Associated with Grapevine Trunk Diseases [PDF]
Toxins, 2011 Up to 60 species of fungi in the Botryosphaeriaceae family, genera Cadophora, Cryptovalsa, Cylindrocarpon, Diatrype, Diatrypella, Eutypa, Eutypella, Fomitiporella, Fomitiporia, Inocutis, Phaeoacremonium and Phaeomoniella have been isolated from decline ...
Antonio Evidente +5 more
doaj +6 more sources
Grapevine trunk diseases of cold-hardy varieties grown in Northern Midwest vineyards coincide with canker fungi and winter injury [PDF]
PLoS ONE, 2022 Grapevine trunk diseases make up a disease complex associated with several vascular fungal pathogenic species. Surveys to characterize the composition of grapevine trunk diseases have been conducted for most major grape growing regions of the world. This
David H. DeKrey +3 more
doaj +4 more sources
Biscogniauxia rosacearum the charcoal canker agent as a pathogen associated with grapevine trunk diseases in Zagros region of Iran [PDF]
Scientific Reports, 2021 Grapevine trunk diseases (GTDs) are well-known and significant fungal diseases of Vitis vinifera with a worldwide distribution. During August to November 2016 in a survey to characterize fungi associated with grapevine trunk diseases in Kermanshah ...
Zeinab Bahmani +3 more
doaj +2 more sources
A Panoramic View on Grapevine Trunk Diseases Threats: Case of Eutypa Dieback, Botryosphaeria Dieback, and Esca Disease [PDF]
Journal of Fungi, 2022 Grapevine trunk diseases (GTD) are currently one of the most devastating and challenging diseases in viticulture, leading to considerable yield losses and a remarkable decline in grapevine quality.
Jihane Kenfaoui +10 more
doaj +2 more sources
Biodegradable, lignin-based encapsulation enables delivery of Trichoderma reesei with programmed enzymatic release against grapevine trunk diseases [PDF]
Materials Today Bio, 2020 Antagonistic fungi such as Trichoderma reesei are promising alternatives to conventional fungicides in agriculture. This is especially true for worldwide occurring grapevine trunk diseases, causing losses of US$1.5 billion every year, at which ...
S. Peil +3 more
doaj +2 more sources
Antifungal Activity of Methylxanthines against Grapevine Trunk Diseases
Agronomy, 2022 Methylxanthines, found in the seeds, leaves, and fruits of some plants, are receiving increasing attention as promising treatments for wood-degrading fungi. The aim of the study presented herein was to explore the potential applications of caffeine, four
Eva Sánchez-Hernández +5 more
doaj +4 more sources
Symptoms and management of grapevine trunk diseases [PDF]
Journal of Central European Agriculture, 2019 Grapevine trunk diseases (GTD) are the most complex fungal diseases currently known on grapevine and according to current knowledge, they are caused by more than 130 species of fungi from different taxonomic classification, whose advance in the perennial
Kristina Grozić +2 more
doaj +2 more sources
Microbiome composition in grapevine trunk diseases symptomatic plants is modulated by genotype and region [PDF]
Scientific ReportsGrapevine health is influenced by microbiome composition, which is affected by region and several plant features such as cultivar, age and rootstock. Grapevine Trunk Diseases (GTDs) are caused by several wood-colonizing fungi, leading to imbalances in ...
Filipe Azevedo-Nogueira +7 more
doaj +2 more sources
Abstracts of oral and poster presentation given at the first COST Action FA 1303 workshop on Grapevine Trunk Diseases, Cognac, France, 23-24 June 2015 [PDF]
Phytopathologia Mediterranea, 2015 The International COST Action FA1303 Workshop on “Sustainable control of Grapevine Trunk Diseases: current state and future prospects” was held in Cognac, France, on June 23-24 2015. The meeting was attended by 90 participants.
doaj +3 more sources
The increasing importance of grapevine trunk diseases
International Journal of Horticultural Science, 2016 Grapevine trunk diseases (GTDs) are destroying the woody parts of the plants, resulting decline or dieback of the grapevine. More detailed research of the GTD began in 1950s, when Hewitt et al. (1957) observed that specific symptoms cannot be detected on
Cs. Kovács, E. Sándor
doaj +3 more sources